Prestige Wealth Management Group LLC Neogenomics Inc Transaction History

Prestige Wealth Management Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$7.06 - $13.97 $282 - $558	40 New	40 $0
Q4 2021 Feb 15, 2022	SELL	$30.49 - $48.49 $9,147 - $14,547	-300 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$41.66 - $52.52 $12,497 - $15,756	300 New	300 $14,000
Q2 2021 Aug 12, 2021	SELL	$36.62 - $51.69 $10,986 - $15,507	-300 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$19.12 - $26.24 $1,912 - $2,624	100 Added 50.0%	300 $6,000
Q2 2019 Aug 16, 2019	SELL	$19.57 - $24.1 $72,252 - $88,977	-3,692 Reduced 94.86%	200 $4,000
Q1 2019 Aug 16, 2019	BUY	$12.14 - $20.46 $47,248 - $79,630	3,892 New	3,892 $80,000

296

125M

698K

116K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.7B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Prestige Wealth Management Group LLC with notifications on news.